European Guidelines on cardiovascular disease prevention in clinical practice

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

The present guidelines have been developed to support healthcare professionals in their efforts to reduce the burden of Atherosclerotic cardiovascular (CV) disease (ASCVD) in both individual patients, as well as at a population level. The previous European Guidelines on CVD prevention in clinical practice were published in 2016. Recent developments in prediction of cardiovascular disease risk and treatment benefit, as well as novel treatments and treatment goals, necessitated new, up-to-date guidelines. The current guidelines on CVD prevention in clinical practice concentrate principally but not exclusively on the risk factors, risk classification, and prevention of ASCVD. The current guidelines provide recommendations on ASCVD prevention to support shared decision-making by the patient and their healthcare professional based on individual patient characteristics. Special considerations have been given to differences in age, sex and gender, life expectancy, risk factor profiles, ethnic, and geographic differences.


Read full Guideline